...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!


BREAKING:  Hollister Biosciences Provides Update on Q2 2020, Generated Record Quarterly Revenue of CDN$ 11.5 Million

  • CDN$ 1.375 million in EBITDA
  • Bureau of Cannabis Control officially renewed its cannabis distribution license for the next year through August 2021
  • "We are very pleased with our revenue growth year to date.  Sales of cannabis related products have proven to be resilient throughout the COVID-19 pandemic.  We hope to continue to deliver strong results as the year progresses" stated Carl Saling, CEO.

Hollister large

Hub On AGORACOM / Read Release

Message: BETonMACE ClinicalTrials.gov update

Just a minor update this week to the BETonMACE ClinicalTrials.gov listing.

The estimated study completion date was changed from "June 2019 [Anticipated]" to "November 30, 2019 [Anticipated]"

I don't think this really means anything. Anticipated dates are very often off from the actual date. And "study completion" is quite vague. Perhaps the study isn't complete until full results are presented and published in November 2019 at AHA and/or ASN?


New Message
Please login to post a reply